First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as $248.15 and last traded at $246.9920, with a volume of 530704 shares changing hands. The stock had previously closed at $246.96.
First Trust NYSE Arca Biotechnology Index Fund Price Performance
The stock has a market cap of $2.79 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68. The business has a fifty day moving average of $216.93 and a 200 day moving average of $210.66.
Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Institutional investors have recently modified their holdings of the company. High Point Wealth Management LLC acquired a new position in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth $26,000. Russell Investments Group Ltd. grew its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. AG Campbell Advisory LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth about $31,000. Cassaday & Co Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the first quarter worth about $34,000. Finally, Parallel Advisors LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% during the 1st quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock worth $37,000 after purchasing an additional 169 shares during the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- JPMorgan Stands by Sky-High Broadcom Target as Shares Slide
- 5 Places Investors Can Hide If the AI Trade Keeps Cracking
- Is Apple’s Latest Plunge the Canary in the Coal Mine for Tech Stocks?
- New Stock Price Highs Are on the Menu for Darden Restaurants
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
